As showed in (Figure 4(b)), NF-κB and phospho-NF-κB levels were upregulated in the CPA patients compared with control patients, indicating that NF-κB was activated in the peri-N of CPA patients. The gene discussed is NFKB1; the disease is congenital primary aphakia.